Date post: | 07-Apr-2018 |
Category: |
Documents |
Upload: | air-me-maslia |
View: | 215 times |
Download: | 0 times |
of 41
8/4/2019 He Mate Me Sis
1/41
UPPERUPPERGASTROINTESTINALGASTROINTESTINAL
BLEEDBLEED
UPPERUPPERGASTROINTESTINALGASTROINTESTINAL
BLEEDBLEED
8/4/2019 He Mate Me Sis
2/41
OutlineIntroductionAetiology of upper GIT bleeding
Diagnosis-history
-physical examination
Management
8/4/2019 He Mate Me Sis
3/41
Upper gastrointestinal
bleeding (UGIB) UGIB is defined as bleeding derived from a
source proximal to the ligament of Treitz.
A potentially life-threatening abdominalemergency
Incidence is approximately 100 cases per 100,000population per year
Common among males and elderly
8/4/2019 He Mate Me Sis
4/41
Aetiology ofupper GI bleed
STOMACH
Gastric ulcers
Gastric erosions
Gastric varices
Haemorrhagic gastritis
Gastric CA
Gastric lymphoma
Gastric polyp
Hereditaryhaemorrhagic telangiectasia
Dieulafoy lesion
Gastric antral
vascular ectasia ( GAVE )
Angiodysplasia
DUODENUM
Duodenal ulcer
Duodenal erosions
Vascular malformation
Aorta-
duodenal fistula
Polyps
( Peutz- Jeghers
and Polyposis coli )
CA of ampulla
CA pancreas
Haemobilia
OESOPHAGUS
Esophageal varises
Mallory Weiss tear
Reflux oesophagitis
Oesophageal ulcer
Barrets ulcer
Cameron ulcer withinhiatus hernia
Oesophageal
neoplasm
8/4/2019 He Mate Me Sis
5/41
Diagnosis
Medical history Extremely helpful in determining thelocation of the GI hemorrhage.
A history of recent nonsteroidal anti-inflammatory drug (NSAID) abuse
Alcohol abuse or a history of cirrhosisshould elicit consideration of portalgastropathy or esophageal varices assources for the bleeding.
History of anticoagulant treatment
8/4/2019 He Mate Me Sis
6/41
Hematemesis Melena Hematochezia Syncope
Dyspepsia Epigastric pain Heartburn Diffuse abdominal pain Dysphagia
Weight loss Jaundice
8/4/2019 He Mate Me Sis
7/41
Physical examination
Vital signs-hypotension,tachycardia,dereasedpulse pressure or tachypnea
Sign of shock-cool,clammy skin
Sign of CLD-palmar
eryhema,jaundice,gyneacomastiaAbdominal-tenderness,ascites,organomegaly
Per rectal-malenic stool
8/4/2019 He Mate Me Sis
8/41
Shock
8/4/2019 He Mate Me Sis
9/41
Management Resuscitation begins with the DRABCs(airway, breathing, circulation)
Assess blood loss and severity Quick history and physical examination
Investigation
Endoscopy, balloon tamponade
Definite management medical or surgery
8/4/2019 He Mate Me Sis
10/41
Airways and Breathing Patients with hemorrhagic shock
present with mental status changesand confusion.
They cannot protect their airway andat increased risk for aspiration,patients must be electively, not
emergently, intubated in a controlledsetting.
Oxygen should be given to all patients.
8/4/2019 He Mate Me Sis
11/41
Circulation Intravenous access must be obtained. Bilateral/two14/ 16-gauge (minimum)
peripheral intravenous lines are
required. Patients with severe coexistingmedical illnesses, may requirepulmonary artery catheter insertionor CVP.
Crytalloids or colloids- 3-for-1 rule.Replace each milliliter of blood loss
with 3 mL of crystalloid fluid.
8/4/2019 He Mate Me Sis
12/41
Fluids Proper fluid management is crucial. Start with a crystalloid, such as
Hartmann's or Ringer's solution. However,any patient with a significant bleed shouldbe treated together with colloid, althoughblood is obviously better.
Those with a life threatening bleed willneed blood as soon as possible, which canbe achieved by using O negative blood
8/4/2019 He Mate Me Sis
13/41
Monitoring response to
resuscitation BP, PR, CVP, urine output, Nasogastric
tube
based on evidence of end organperfusion and oxygen delivery; skintemp. serum bicarbonate
8/4/2019 He Mate Me Sis
14/41
Blood tests Serial Full blood count.
Clotting screen: The coagulopathy could be amarker for advanced liver disease.
Urea and electrolytes. Blood in the stomach willbe digested as protein and will be broken down bythe liver into urea, resulting in an elevated urea
concentration. Azotemia. The BUN-to-creatinine >36 without renal insufficiency is suggestive ofUGIB.
Group and cross match. mild cases 2-4 units ofblood. severe 6-20 units, depending on the
patient's condition.
8/4/2019 He Mate Me Sis
15/41
Endoscopy For diagnostic and therapeutic
Early intervention to control bleeding and preventrebleeding Timing: within 12 to 24 hrs after presentation of
bleeding Provided that patient is stabilized Try to remove any clot to visualize the site Biopsy of GIT mucosa is taken during scope for
Clo test (to detect H. pylori infection, resultavailable after 24-hr)
8/4/2019 He Mate Me Sis
16/41
Techniques for hemostasis
Injection vasoactive agents
sclerosing agents
Mechanical Rubber band ligation
Application of hemostatic materials, includingbiologic glue, clips
Coagulation Bipolar electrocoagulation Thermal probe coagulation
Constant probe pressure tamponade
Argon plasma coagulator
Laser photocoagulation
8/4/2019 He Mate Me Sis
17/41
Drug therapy Infusion of somatostatin and it
synthetic,octreotide are effective in reducingbleeding from varices or peptic ulcer.
-Dose of octreotide:50g iv bolus, followed by 50g8-24hr
Dose of somatostatin:250-500 g iv bolus,followed250-500 g perhour
Proton-pump inhibitors :
Omeprazole ( iv omeprazole 80mg stat followed by
infusion 8mg hourly for 72hrs ) is recommendedfollowing endoscopic therapy
Iv pantoprazole also can be used
Helicobacter pylori eradication
8/4/2019 He Mate Me Sis
18/41
Helicobacter pylori eradication
therapy Proton-pump inhibitors along with two
antibiotics for 1 week :
- Omeprazole 20mg and metronidazole400mg or amoxycillin 1g andclarythromycin 500mg(all twice daily )
8/4/2019 He Mate Me Sis
19/41
Ballon Tamponade-sengstaken blakemore tube
-control variceal hemorrhage in 40-80% of patient
Surgery-who do not respond to medical therapy andendoscopic hemostatic
8/4/2019 He Mate Me Sis
20/41
8/4/2019 He Mate Me Sis
21/41
8/4/2019 He Mate Me Sis
22/41
Indications for surgery Severe life-threatening hemorrhage not
responsive to resuscitative efforts Failure of medical therapy and endoscopic
hemostasis with persistent recurrent bleeding
A coexisting reason for surgery such asperforation, obstruction, or malignancy
Prolonged bleeding with loss of 50% or more ofthe patient's blood volume
A second hospitalization for peptic ulcerhemorrhage
8/4/2019 He Mate Me Sis
23/41
8/4/2019 He Mate Me Sis
24/41
THANK YOU
8/4/2019 He Mate Me Sis
25/41
Referrences
Guide to the essentials in emergency medicine:Shirley Ooiand Peter manning
Gastrointestinal emergency: David T.overton
Garden, O. J., W.Bradbury, A., & Forsythe, J. (2002).Principles and Practice of Surgery(Fourth Edition ed.):Churchill Livingstone
8/4/2019 He Mate Me Sis
26/41
Forrest Classification for
bleeding peptic ulcer Ia: spurting bleeding Ib: non spurting active bleeding
IIa: Visible vessel (no active bleeding) IIb: Non bleeding ulcer with overlying clot (no visible vessel) IIc: Ulcer with hematin covered base
III: Clean ulcer ground (no clot, no vessel)
Stigmata of Recent Haemorrhage: Major SRH, Minor SRH
8/4/2019 He Mate Me Sis
27/41
Common sites of portal-systemic collateral formationLocation Portal circulation Systemic circulationClinical
consequence
Proximal stomach and
distal esophagus
Coronary vein of
stomach
Azygos vein Submucosal
gastroesophageal
varicesAnterior abdominal
wall
Umbilical vein in
falciform ligament
Epigastric
abdominal wall veins
Caput medusae
Retroperitoneal Splenic vein branch
Sappey's veins (around
liver and diaphragm)
Left renal vein
Retzius's vein
Usually none
Anorectal Middle and superior
hemorrhoidal veins
Inferior
hemorrhoidal vein
May be mistaken
for hemorrhoids
8/4/2019 He Mate Me Sis
28/41
8/4/2019 He Mate Me Sis
29/41
8/4/2019 He Mate Me Sis
30/41
8/4/2019 He Mate Me Sis
31/41
8/4/2019 He Mate Me Sis
32/41
8/4/2019 He Mate Me Sis
33/41
8/4/2019 He Mate Me Sis
34/41
8/4/2019 He Mate Me Sis
35/41
8/4/2019 He Mate Me Sis
36/41
8/4/2019 He Mate Me Sis
37/41
8/4/2019 He Mate Me Sis
38/41
8/4/2019 He Mate Me Sis
39/41
8/4/2019 He Mate Me Sis
40/41
8/4/2019 He Mate Me Sis
41/41